Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Lacidipine 2 mg, 4 mg Tablets, film coated Glaxo Wellcome SA., Aranda de Duero, Spain and Glaxo Wellcome SpA., San Polo di Torrile, Parma, Italy Lacipil Egg-yolk phospholipid 1.2% w/v, glycerol 2.5% w/v, medium chain triglycerides 5% w/v, soya oil 5% w/v Infusion, solution B Braun Melsungen AG., Melsungen, Germany Lipofundin MCT/LCT 10% Egg-yolk phospholipid 1.2% w/v, glycerol 2.5% w/v, medium chain triglycerides 10% w/v, soya oil 10% w/v Infusion, solution B Braun Melsungen AG., Melsungen, Germany Lipofundin MCT/LCT 20% Pravastatin sodium 10 mg, 20 mg Tablets Bristol-Myers Squibb Australia Pty Limited, Noble Park, Victoria, Australia Lipostat Pink tablet: Ethinyloestradiol 20 g, levonorgestrel 100 g Green tablet: Lactose q.s. Tablets, film coated Ayerst-Wyeth Pharmaceuticals Inc., Barrios Pozo Hondos & Jobos, Guayama, Puerto Rico Loette Ethinyloestradiol 20 g, levonorgestrel 100 g Tablet, film coated Ayerst-Wyeth Pharmaceuticals Inc., Barrios Pozo Hondos & Jobos, Guayama, Puerto Rico Loette 21 Gabapentin 100 mg, 300 mg, 400 mg Capsules, powder filled Godecke AG., Freiburg, Germany Neurontin Ranitidine bismuth citrate 400 mg Tablet, film coated Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom Pylorid Simvastatin 80 mg Tablet, film coated Merck Sharp & Dohme Limited, Cramlington, Northumberland, England Zocor Ondansetron hydrochloride (dihydrate) 2 mg/mL Injection, solution (glass ampoule) Glaxo Wellcome Operations, Barnard Castle, County Durham, United Kingdom Zofran Ondansetron hydrochloride (dihydrate) 2 mg/mL Injection, solution (plastic ampoule) Glaxo Wellcome Australia Limited, Boronia, Victoria, Australia Zofran Dated this 11th day of August 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.